Page 7 - IJB-7-4
P. 7

Zhuang, et al.
           non-tumor fraction houses stromal cells mainly including   barrier involving basement membrane remodeling during
           fibroblasts  and  myofibrolasts,  adipocyte,  blood  and   tumor angiogenesis and tumorigenesis. In addition,
           lymphatic vascular networks, infiltrating immune cells,   pericytes  also  regulate  leukocytes  transmigration  and
           and the non-cellular ECM , as shown in Figure 1. The   elicit  phagocytic  activity . In addition,  TECs, with
                                                                                     [28]
                                 [23]
           major cell types in TME include immune cells, stromal   irregular shape and size, build up the inner layer of blood
           cells, and tumor endothelial cells (TECs). Immune cells   vessels of the tumor and involve in tumor angiogenesis,
           such  as macrophages,  dendritic  cells  (DCs), myeloid-  progression, metastasis,  and chemo  drugs resistance .
                                                                                                            [29]
           derived suppressor cells (MDSCs), CD4/CD8 T cells, and   Through providing a leaking vascular system, impaired
           regulatory T cells (Tregs) play a key role in tumor immune   blood  flow,  as  well  as  a  high-interstitial-fluid-pressure,
           evasion .  These  immune  cells  in  TME  present  the   hypoxia, and acidic environment, the disorganized TECs
                 [26]
           resistance to immunosurveillance which recognizes and   are key factors of tumor progression . The ECM is a 3D
                                                                                             [24]
           destroys foreign pathogens. Moreover, tumor-associated   network  of extracellular  macromolecules  composed  of
           macrophages  (TAMs) also promote  angiogenesis  and   collagen, laminin, fibronectin, hyaluronan, proteoglycan,
           metastasis by producing multiple cytokines, including   and other biopolymers  with varied  concentrations  and
           vascular endothelial growth factor A (VEGF-A), tumor   organizations  (Figure  1); therefore,  the  ECM exists in
           necrosis factor  α (TNFα), and interleukin  6 (IL-6) .   various elasticities and dimensional stiffness.
                                                        [24]
           Stromal  cells,  including  cancer-associated  fibroblasts   It is well documented that stiffness of tumor is higher
           (CAFs), mesenchymal  stromal  cells  (MSCs), and    than that of the normal tissue and will vary across tumor
           pericytes contribute to the structure of TME and promote   grade . On tissue damage,  an increasing  number of
                                                                   [30]
           growth, invasion, as well as metastasis of tumors. MSCs   CAFs are detected within the tumor. These myofibroblasts
           in  TME, a kind of multipotent  progenitor  cells,  can   are thought to be “activated” fibroblasts and will engage
           differentiate into multiple connective tissues to exacerbate   to promote the tumor progression . Specifically, breast
                                                                                           [31]
           tumor  desmoplasia,  proliferation, and angiogenesis .   tumor  has  shown  a  stiffer  microenvironment  (4  kPa)
                                                        [27]
           Pericytes, along with endothelial cells, act as a physical   compared to the healthy breast tissue (150~200 Pa). In









































           Figure 1. A schematic view of cellular components and extracellular matrix compositions of tumor microenvironment (TME). TME not
           only houses tumor cells but also includes stromal cells and infiltrating immune cells. Limited perfusion and tumor expansion establish a
           gradient of oxygen availability from the blood vessels to the adjacent tumor cells in the acidic environment.

                                       International Journal of Bioprinting (2021)–Volume 7, Issue 4         3
   2   3   4   5   6   7   8   9   10   11   12